Issue No. 4 2019 First Quarter Newsletter We are delighted to announce the release of our latest issue of the AATOD Newsletter. In this 2019 first quarter issue, you will read about several opioid disorder topics written by several of our Board members and AATOD staff members. #opioids #newsletter #2019 #opioidaddiction #criminaljusticesystem
Early Registration Deadline TONIGHT! Don't miss your chance to save and get registered for this amazing experience. While much of the country is enduring very frigid conditions this week, we here in Florida are struggling through the weather in the 50's and 60's, not bragging, just saying won't it be wonderful to get registered and start thinking about hanging out here in 70 to 80 degree, sunny weather for our conference! May help you get through the cold blast. We hope you will join us in sunny and warm Florida on October 19 - 23, 2019. #earlyregistrationdeadline #registernow #aatod2019 #ceus #medicalconference #opioids #opioidcrisis
ABSTRACT SUBMISSION Deadline EXTENDED to January 25, 2019! #callforpresentations #painmanagement #medicalconference #opioids #addictiontreatment
Call for Presentations deadline is this Friday, January 18th. These are some suggested topics for submission. To view the CFP brochure, please visit our bio link. #aatod #cfp #callingpresentations #medicalconference #ceus #opioidcrisis #criminaljustice #painmanagement
AATOD is now accepting proposals for workshop and poster presentations for the 2019 AATOD Conference. The conference is being held in sunny Florida, October 19-23, 2019, at the Disney’s Coronado Springs Resort.
Opioid Legislation Signed into Law by President Trump - October 24, 2018 President Trump signed the sweeping opioid legislation into law Wednesday afternoon at a White House ceremony. It was a very well attended event, including Cabinet members, legislators, leadership from our field and business leaders, especially from the large pharmacy retail groups. Mrs. Trump also made opening remarks reflecting the work of the people behind the podium, including our own Dr. Loretta Finnegan, for her work in the MATER program in Philadelphia, treating women and their children. It represented a lovely acknowledgement of Dr. Finnegan's work in our field in developing the earliest comprehensive treatment program, specializing in the treatment of women suffering from opioid use disorder. President Trump provided a summary of the major components of the bill and also cited the work of his administration. From our point of view, one of the major elements of the package authorizes the development of a Medicare reimbursement rate for OTP services and medications when treating Medicare eligible patients in OTPs. Thank you once again for your support and your letters to so many elected officials. Our patients are the ultimate beneficiaries.
The National Prescription Drug Take Back Day - 10.27.18 takebackday.dea.gov #dea #prescriptiondrugs #opioids #rx
#savethedate #aatod2019 #orlandoflorida #aatod #aatodconference
The AATOD Board of Directors is on Capitol Hill today with members of Survivors Council and AORecovery to promote Medicare coverage for OTPs! #opioidepidemic #opioideducation #hillvisits #medicare #accessMATters #todayindc #medicaidassistedtreatment